Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Unknown 3

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 1

Conditions

Xeroderma Pigmentosum 2Keratosis, Actinic 1Carcinoma, Squamous Cell 1

Interventions

pembrolizumab 1033Carboplatin 971Paclitaxel 942Gemcitabine 799Cisplatin 757Docetaxel 698Bevacizumab 637Nivolumab 520Pemetrexed 507Capecitabine 475Cyclophosphamide 473Fluorouracil 425Dexamethasone 410Rituximab 391Oxaliplatin 352Injections 347Trastuzumab 314atezolizumab 312Cetuximab 291Leucovorin 290Irinotecan 271130-nm albumin-bound paclitaxel 257Prednisone 251Ipilimumab 244Doxorubicin 241Lenalidomide 231Fulvestrant 226fludarabine 219durvalumab 211Erlotinib Hydrochloride 196

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × afamelanotide × Clear all
NCT05370235 2023-09-21

A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum C and V

Clinuvel Pharmaceuticals Limited

Phase 2 Unknown
6 enrolled

Xeroderma Pigmentosum

NCT05159752 2023-06-18

A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum (XP)

Clinuvel Pharmaceuticals Limited

Phase 2 Unknown
6 enrolled

Xeroderma Pigmentosum

NCT00829192 2010-12-06

Phase II AK Study in Organ Transplant Patients

Clinuvel Pharmaceuticals Limited

Phase 2 Unknown
200 enrolled
Dermatologic

Carcinoma, Squamous Cell, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡